Suppr超能文献

相似文献

1
TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis.
Cell. 2008 May 2;133(3):415-26. doi: 10.1016/j.cell.2008.03.026.
2
MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2.
Cell Death Dis. 2014 Feb 27;5(2):e1095. doi: 10.1038/cddis.2014.47.
3
Research progress of TIPE2 in immune-related diseases.
Int Immunopharmacol. 2023 Aug;121:110514. doi: 10.1016/j.intimp.2023.110514. Epub 2023 Jun 20.
4
TIPE2 as a potential therapeutic target in chronic viral hepatitis.
Expert Opin Ther Targets. 2019 Jun;23(6):485-493. doi: 10.1080/14728222.2019.1608948. Epub 2019 Apr 22.
5
TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury.
J Mol Med (Berl). 2015 Sep;93(9):1033-43. doi: 10.1007/s00109-015-1288-9. Epub 2015 Apr 17.
6
Ymer acts as a multifunctional regulator in nuclear factor-κB and Fas signaling pathways.
Mol Med. 2012 May 9;18(1):587-97. doi: 10.2119/molmed.2011.00435.
7
TIPE2 (Tumor Necrosis Factor α-induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal.
J Biol Chem. 2016 Oct 21;291(43):22650-22660. doi: 10.1074/jbc.M116.733451. Epub 2016 Sep 6.
9
TIPE2 in dendritic cells inhibits the induction of pTregs in the gut mucosa.
Biochem Biophys Res Commun. 2019 Feb 19;509(4):911-917. doi: 10.1016/j.bbrc.2019.01.008. Epub 2019 Jan 11.
10
Gene delivery of TIPE2 attenuates collagen-induced arthritis by modulating inflammation.
Int Immunopharmacol. 2020 Feb;79:106044. doi: 10.1016/j.intimp.2019.106044. Epub 2019 Dec 18.

引用本文的文献

1
4
TIPE2 combined with immune cell infiltration predicts prognosis in colorectal cancer.
Sci Rep. 2025 Jul 31;15(1):27954. doi: 10.1038/s41598-025-10449-5.
5
Targeting PBK with small-molecule 1--acetyl-4,6-britannilactone for the treatment of neuroinflammation.
Proc Natl Acad Sci U S A. 2025 Jul 22;122(29):e2502593122. doi: 10.1073/pnas.2502593122. Epub 2025 Jul 14.
6
TIPE2: a novel regulatory factor for cardiovascular-related diseases.
J Mol Med (Berl). 2025 Jun 19. doi: 10.1007/s00109-025-02564-7.
9
MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy.
Cancer Gene Ther. 2025 Apr;32(4):371-392. doi: 10.1038/s41417-025-00886-9. Epub 2025 Mar 26.

本文引用的文献

1
Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling.
J Biol Chem. 2007 Mar 9;282(10):7416-23. doi: 10.1074/jbc.M606721200. Epub 2007 Jan 9.
2
TGF-beta: a mobile purveyor of immune privilege.
Immunol Rev. 2006 Oct;213:213-27. doi: 10.1111/j.1600-065X.2006.00437.x.
3
Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation.
Curr Biol. 2006 Aug 22;16(16):1666-71. doi: 10.1016/j.cub.2006.06.062.
4
Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA.
J Immunol. 2006 Apr 15;176(8):4520-4. doi: 10.4049/jimmunol.176.8.4520.
5
Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression.
Mol Ther. 2006 May;13(5):947-55. doi: 10.1016/j.ymthe.2005.11.020. Epub 2006 Feb 7.
6
Caspase-8 deficiency in T cells leads to a lethal lymphoinfiltrative immune disorder.
J Exp Med. 2005 Sep 19;202(6):727-32. doi: 10.1084/jem.20050683. Epub 2005 Sep 12.
7
Requirement for caspase-8 in NF-kappaB activation by antigen receptor.
Science. 2005 Mar 4;307(5714):1465-8. doi: 10.1126/science.1104765.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验